Chimerix is a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases.
Press Releases
| Date | Title |
|---|---|
| Dec 09, 2024 | |
| Dec 06, 2024 | |
| Nov 11, 2024 | |
| Nov 07, 2024 |
Presentations
Upcoming Events
SEC FILINGS
| Filing date | Form | Description | View |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| CT ORDER | CT ORDER |
View HTML | |
| CT ORDER | CT ORDER |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML | |
| 10-K | Annual report which provides a comprehensive overview of the company for the past year |
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT | |
| S-8 | Securities offered to employees pursuant to employee benefit plans |
View HTML | |
| SC 13G/A | An amendment to the SC 13G filing |
View HTML | |
| SC 13G | A statement of beneficial ownership of common stock by certain persons |
View HTML |
FAQ
The Chimerix ticker is CMRX and it is traded on the Nasdaq Global Market.
2505 Meridian Parkway, Suite 100, Durham, NC 27713
You can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website.
You can view our management team by visiting the Management section of our Investor Relations website.
December 31
Chimerix does not expect to declare or pay any cash or other dividends on our common stock.
Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov.
The transfer agent and registrar for our common stock is: Computershare Trust Company, N.A. The transfer agent and registrar’s address is: P.O. Box 43078 Providence, Rhode Island 02940
Archived Events
| Date | Details |
|---|---|
|
Dec 10, 2024 at
8:30 AM EST |
|
|
Nov 7, 2024 at
8:30 AM EST |
|
|
Sep 9, 2024 at
7:00 AM EDT |